Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Journal of Pharmaceutical Sciences|September 6, 2020
Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug RepurposingBrian Jermain, Patrick O Hanafin, Yanguang Cao, et al.Journal of Orthopaedic Surgery and Research|July 27, 2023
The prevalence of osteoporotic fractures in the elderly in China: a systematic review and meta-analysisShilong Meng, Minghao Tong, Yang Yu, et al.CPT: Pharmacometrics & Systems Pharmacology|November 16, 2023
Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug developmentWei Gao, Jiang Liu, Blerta Shtylla, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 22, 2019
Mathematical modeling of the heterogeneous distributions of nanomedicines in solid tumorsHua He, Can Liu, Yuhui Liu, et al.Blood Cancer Discovery|October 27, 2025
A Pharmacologic Model Predicts that Tumor Debulking Improves CAR T-cell Efficacy in Large B-cell LymphomaAmy E Pomeroy, Brian J Sworder, Deborah Plana, et al.Materials (Basel, Switzerland)|July 30, 2025
Stress-Strain and Structural Evolution on the Localized Interface of Stainless Steel Clad PlateYinpeng Wang, Bo Gao, Qiqing Tian, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 3, 2026
New approach methodologies (NAMs) for preclinical and translational evaluation of mRNA-lipid nanoparticle (LNP) therapeuticsJiawei Zhou, Nan Li, Rihe Liu, et al.Journal of Ethnopharmacology|April 10, 2025
New Qiangguyin activates Wnt/β-catenin pathway by down-regulating Notum to improve osteoporosis in ratsXu Zhang, Shilong Meng, Yawei Xu, et al.Advanced Biology|June 27, 2024
New-QiangGuYin-Containing Serum Inhibits Osteoclast-Derived Exosome Secretion and Down-Regulates Notum to Promote Osteoblast DifferentiationShilong Meng, Xu Zhang, Yang Yu, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 4, 2018
Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney DiseaseJames J Beaudoin, Jacqueline Bezençon, Yanguang Cao, et al.Pageof 8